Study of the Effectiveness of Vestibular Stimulation as a Coadjuvant Treatment in Major Depression

Major depression is characterized by vestibular anomalies. The investigators hypothesized that vestibular stimulation will improve depression symptoms in major depression patients.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Depression Behavior Behavioral Symptoms Depressive Disorder Depressive Disorder, Major Major Depression Mental Disorders Mood Disorders Vestibular Disorders

Age range

18 year–70 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Centro de Medicina Aeroespacial

Santiago, Santiago Metropolitan, Chile

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

major depression patients,
actual Hamilton score > 14

Exclusion criteria

pregnant,
neurological disorders,
epilepsy,
bipolar disorder,
schizophrenia,
anorexia,
bulimia.

Treatment and study plan

vestibular stimulation

Other

vestibular stimulation

Primary outcomes

Hamilton depression rating score

Time frame: 1 month after the treatment start

Sponsors and collaborators

Lead sponsor

Fuerza Aérea de Chile

Other Gov

Collaborators

Pontificia Universidad Catolica de Chile

Registry information

Official study title

Clinical Randomized Trial to Evaluate the Efficacy of Vestibular Stimulation as Coadjuvant Therapy in Major Depression

Important dates

Study start: 2011
Primary completion: 2012
Study completion: 2012
First posted: Jul 22, 2011
Registry last updated: Mar 5, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed